As of 2026-03-19, the Relative Valuation of Theravance Biopharma Inc (TBPH) is 7.21 USD. This relative valuation is based on P/E multiples. With the latest stock price at 13.83 USD, the upside of Theravance Biopharma Inc based on Relative Valuation is -47.9%.
The range of the Relative Valuation is 4.19 - 10.92 USD.
| Range | Selected | |
| Trailing P/E multiples | 7.2x - 13.8x | 10.2x |
| Forward P/E multiples | 10.6x - 18.9x | 14.7x |
| Fair Price | 4.19 - 10.92 | 7.21 |
| Upside | -69.7% - -21.0% | -47.9% |
| Date | P/E |
| 2026-03-13 | 23.79 |
| 2026-03-12 | 23.98 |
| 2026-03-11 | 23.85 |
| 2026-03-10 | 24.23 |
| 2026-03-09 | 24.17 |
| 2026-03-06 | 23.43 |
| 2026-03-05 | 23.45 |
| 2026-03-04 | 23.60 |
| 2026-03-03 | 24.11 |
| 2026-03-02 | 32.72 |
| 2026-02-27 | 31.51 |
| 2026-02-26 | 31.41 |
| 2026-02-25 | 32.91 |
| 2026-02-24 | 32.91 |
| 2026-02-23 | 33.26 |
| 2026-02-20 | 33.95 |
| 2026-02-19 | 33.55 |
| 2026-02-18 | 33.10 |
| 2026-02-17 | 32.48 |
| 2026-02-13 | 33.72 |
| 2026-02-12 | 33.50 |
| 2026-02-11 | 33.69 |
| 2026-02-10 | 33.50 |
| 2026-02-09 | 33.67 |
| 2026-02-06 | 35.36 |
| 2026-02-05 | 33.81 |
| 2026-02-04 | 34.69 |
| 2026-02-03 | 34.52 |
| 2026-02-02 | 34.24 |
| 2026-01-30 | 32.70 |
| 2026-01-29 | 33.12 |
| 2026-01-28 | 32.86 |
| 2026-01-27 | 34.22 |
| 2026-01-26 | 34.10 |
| 2026-01-23 | 34.95 |
| 2026-01-22 | 35.81 |
| 2026-01-21 | 35.17 |
| 2026-01-20 | 35.26 |
| 2026-01-16 | 34.55 |
| 2026-01-15 | 34.73 |
| 2026-01-14 | 35.59 |
| 2026-01-13 | 35.10 |
| 2026-01-12 | 33.93 |
| 2026-01-09 | 32.88 |
| 2026-01-08 | 32.84 |
| 2026-01-07 | 32.60 |
| 2026-01-06 | 31.60 |
| 2026-01-05 | 31.81 |
| 2026-01-02 | 31.34 |
| 2025-12-31 | 32.31 |